What is the difference between sexual and asexual reproduction in plant patents?

In the context of plant patents, the distinction between sexual and asexual reproduction is crucial. The MPEP 2121.03 highlights this difference in discussing the In re LeGrice case: “There was no evidence of commercial availability in enabling form since the asexually reproduced rose could not be reproduced from seed. Therefore, the public would not have…

Read More

When is a claim’s eligibility considered self-evident?

A claim’s eligibility is considered self-evident when it clearly does not attempt to monopolize a judicial exception. The MPEP 2106.06(a) states: “Such claims do not need to proceed through the full analysis herein as their eligibility will be self-evident.” Examples of self-evident eligibility include: Complex manufactured industrial products or processes with meaningful limitations Claims that…

Read More

What are examples of claims with self-evident eligibility?

The MPEP 2106.06(a) provides several examples of claims with self-evident eligibility: Robotic arm assembly: “A robotic arm assembly having a control system that operates using certain mathematical relationships is clearly not an attempt to tie up use of the mathematical relationships and would not require a full analysis to determine eligibility.” Artificial hip prosthesis: “A…

Read More

How do you select the appropriate counterpart for the markedly different characteristics analysis?

Selecting the appropriate counterpart is a crucial step in the markedly different characteristics analysis. The MPEP provides guidance on this process: “Because the markedly different characteristics analysis compares the nature-based product limitation to its naturally occurring counterpart in its natural state, the first step in the analysis is to select the appropriate counterpart(s) to the…

Read More

What constitutes “secret use” in patent law?

What constitutes “secret use” in patent law? In patent law, “secret use” refers to the use of an invention that is kept confidential and not accessible to the public. The Manual of Patent Examining Procedure (MPEP) 2152.02(c) states: “An inventor’s private use or sale of the invention is not prior art under AIA 35 U.S.C.…

Read More

Can a secret use of an invention constitute public use?

Yes, in some circumstances, a secret or confidential use of an invention can constitute public use under pre-AIA 35 U.S.C. 102(b). The MPEP explains: “[S]ecrecy of use alone is not sufficient to show that existing knowledge has not been withdrawn from public use; commercial exploitation is also forbidden.” (MPEP 2133.03(a)) This means that even if…

Read More